Literature DB >> 25639730

RhoGAPs and Rho GTPases in platelets.

Margitta Elvers1.   

Abstract

Platelet cytoskeletal reorganization is essential for platelet adhesion and thrombus formation in hemostasis and thrombosis. The Rho GTPases RhoA, Rac1 and Cdc42 are the main players in cytoskeletal dynamics of platelets responsible for the formation of filopodia and lamellipodia to strongly increase the platelet surface upon activation. They are involved in platelet activation and aggregate formation including platelet secretion, integrin activation and arterial thrombus formation. The activity of Rho GTPases is tightly controlled by different proteins such as GTPase-activating proteins (GAPs). GAPs stimulate GTP hydrolysis to terminate Rho signaling. The role and impact of GAPs in platelets is not well-defined and many of the RhoGAPs identified are not known to be present in platelets or to have any function in platelets. The recently identified RhoGAPs Oligophrenin1 (OPHN1) and Nadrin regulate the activity of RhoA, Rac1 and Cdc42 and subsequent platelet cytoskeletal reorganization, platelet activation and thrombus formation. In the last years, the analysis of genetically modified mice helped to gain the understanding of Rho GTPases and their regulators in cytoskeletal rearrangements and other Rho mediated cellular processes in platelets.

Entities:  

Keywords:  Cytoskeleton; Rho GTPases; RhoGAP; nadrin; oligophrenin1; platelet

Mesh:

Substances:

Year:  2015        PMID: 25639730     DOI: 10.5482/HAMO-14-09-0046

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  4 in total

1.  DLGAP1 directs megakaryocytic growth and differentiation in an MPL dependent manner in hematopoietic cells.

Authors:  Boguslaw A Kwiatkowski; Nicolas R Burwick; Robert E Richard
Journal:  Biomark Res       Date:  2019-07-08

Review 2.  Turning Platelets Off and On: Role of RhoGAPs and RhoGEFs in Platelet Activity.

Authors:  Shane P Comer
Journal:  Front Cardiovasc Med       Date:  2022-01-06

3.  Another piece of knowledge in the puzzle of procoagulant COAT platelets.

Authors:  Alessandro Aliotta; Lorenzo Alberio
Journal:  J Thromb Haemost       Date:  2022-05       Impact factor: 16.036

4.  Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics.

Authors:  Benjamin E Tourdot; Hannah Stoveken; Derek Trumbo; Jennifer Yeung; Yogendra Kanthi; Leonard C Edelstein; Paul F Bray; Gregory G Tall; Michael Holinstat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-10       Impact factor: 8.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.